KR870700358A - 약물제조방법 및 그 용도 - Google Patents

약물제조방법 및 그 용도

Info

Publication number
KR870700358A
KR870700358A KR860700853A KR860700853A KR870700358A KR 870700358 A KR870700358 A KR 870700358A KR 860700853 A KR860700853 A KR 860700853A KR 860700853 A KR860700853 A KR 860700853A KR 870700358 A KR870700358 A KR 870700358A
Authority
KR
South Korea
Prior art keywords
drug manufacturing
drug
manufacturing
Prior art date
Application number
KR860700853A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR870700358A publication Critical patent/KR870700358A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR860700853A 1985-03-29 1986-11-29 약물제조방법 및 그 용도 KR870700358A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853511609 DE3511609A1 (de) 1985-03-29 1985-03-29 Arzneimittel, dessen herstellung und verwendung
PCT/KR1986/000008 WO1986005689A1 (en) 1985-03-29 1986-03-29 Drug, preparation and use thereof

Publications (1)

Publication Number Publication Date
KR870700358A true KR870700358A (ko) 1987-12-28

Family

ID=6266818

Family Applications (1)

Application Number Title Priority Date Filing Date
KR860700853A KR870700358A (ko) 1985-03-29 1986-11-29 약물제조방법 및 그 용도

Country Status (11)

Country Link
US (1) US4918099A (ko)
EP (1) EP0205775A3 (ko)
KR (1) KR870700358A (ko)
AU (1) AU5527786A (ko)
DE (1) DE3511609A1 (ko)
DK (1) DK573386A (ko)
GB (1) GB2173500A (ko)
GR (1) GR860828B (ko)
NZ (1) NZ215678A (ko)
WO (1) WO1986005689A1 (ko)
ZA (1) ZA862351B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3259393A (en) * 1991-11-29 1993-06-28 Bioxytech Method for assaying the sod activity by using a self-oxidizable compound necessary for its implementation, self-oxidizable compounds and preparation thereof
FR2684378B1 (fr) * 1991-11-29 1994-12-23 Bioxytech Procede de dosage de l'activite sod utilisant la braziline ou l'un de ses derives, necessaires pour sa mise en óoeuvre, composes derives de la braziline et leur preparation.
GB9704904D0 (en) * 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition
KR100362941B1 (ko) * 1999-05-17 2002-11-30 한국과학기술연구원 헤마테인을 함유하는 고지혈증 및 동맥경화증 예방 및 치료용 조성물
US6238696B1 (en) 2000-01-07 2001-05-29 Gaia Herbs, Inc. Process for providing herbal medicants in cellulose derivative capsules
JP2005501851A (ja) * 2001-08-13 2005-01-20 ハーグリーブス リレイ,マイケル 毒素を除去するための組成物
US6585998B2 (en) * 2001-11-13 2003-07-01 Rudolph Cartwright Nutraceutical composition
KR100362940B1 (ko) * 2002-05-17 2002-11-30 한국과학기술연구원 헤마테인을 함유하는 고지혈증 및 동맥경화증 예방 및치료용 조성물
US20050118324A1 (en) * 2003-12-02 2005-06-02 Mathew Anna M. Good living tea - a diabetic dietary supplement drink
KR100888840B1 (ko) * 2008-08-25 2009-03-17 (주)케이피티 광안정성을 향상시킨 천연색소를 염착한 셀룰로오스를 함유하는 화장료 원료용 조성물, 및 이를 포함하는 비쥬얼 운반 시스템
TWI375671B (en) * 2010-03-01 2012-11-01 Univ China Medical Pharmaceutical compositions containing brazilin for inhibiting expression of cytokines of t helper cell type ii and/or inhibiting expression of chemokines and uses of the same
KR102088768B1 (ko) * 2018-05-15 2020-03-17 한림대학교 산학협력단 소목(Caesalpinia eriostachys Benth) 추출물을 유효성분으로 함유하는 통증 예방 또는 치료용 조성물
WO2021170093A1 (zh) * 2020-02-26 2021-09-02 上海科技大学 双硫仑在抗冠状病毒中的应用
CN114133446A (zh) * 2021-12-31 2022-03-04 方坦思(上海)生物医药有限公司 单克隆抗体的纯化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US637707A (en) * 1898-01-06 1899-11-21 Francis Emile Bucher Process of treating logwood extracts.
FR319945A (fr) * 1902-03-25 1902-11-27 Jacquemin Procédé de fabrication industrielle de l'hématéine, par oxydation directe de l'hématoxyline
GB190406428A (en) * 1904-03-16 1904-04-21 Roberto Lepetit Improvements in and relating to the Manufacture of a Condensation Product from Haematoxylin and Formaldehyde.
US1720278A (en) * 1920-04-19 1929-07-09 Elmer H King Chemical substance
GB1281526A (en) * 1968-10-25 1972-07-12 Lawson Tait Medical And Scient Therapeutic compositions
US4147691A (en) * 1977-03-31 1979-04-03 University Of Iowa Research Foundation Process for the extraction and purification of cesalin
US4363669A (en) * 1979-12-05 1982-12-14 Merck & Co., Inc. Dispersible xanthan gum blends
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion

Also Published As

Publication number Publication date
DE3511609C2 (ko) 1987-06-19
DK573386A (da) 1987-01-22
EP0205775A3 (de) 1990-02-14
EP0205775A2 (de) 1986-12-30
ZA862351B (en) 1986-11-26
GR860828B (en) 1986-07-28
WO1986005689A1 (en) 1986-10-09
GB2173500A (en) 1986-10-15
DE3511609A1 (de) 1986-10-02
DK573386D0 (da) 1986-11-28
AU5527786A (en) 1986-10-02
US4918099A (en) 1990-04-17
GB8607817D0 (en) 1986-04-30
NZ215678A (en) 1988-11-29

Similar Documents

Publication Publication Date Title
KR860008855A (ko) 호스 구조물 및 이의 제법
KR880700319A (ko) 장치 및 그 제조방법
KR870700343A (ko) 진주광택 샴푸 및 이의 제조방법
DE3669997D1 (de) Rollstuhl und anwendungsweise.
KR890016266A (ko) 전주 및 그 제조방법과 전주조립체
DK151686A (da) Hydroxamater
KR870700332A (ko) 실금 보호대 및 그 제조방법
DE3675824D1 (de) Antianaphylaktische und antibronchospastische n-benzhydrylcycloalkylalkananilide.
KR860005526A (ko) 관통 캐패시터 장치 및 그 제조방법
KR880700326A (ko) 효율적인 홀로 그램 및 그 제조방법
KR890700372A (ko) 확장체 부착 카테테르 및 그 제조방법
KR870700358A (ko) 약물제조방법 및 그 용도
KR860005765A (ko) 강인성 세라믹스 및 그 제조방법
DE220574T1 (de) Menschliches interferon-beta2a und interferon-beta2b
KR870001886A (ko) 주조용 노즐 및 그 제조방법
DK139286A (da) Inden- og naphthalenderivater
DE3680771D1 (de) Isoxazolopyridophenoxazin- und isothiazolopyridophenoxazinderivate.
KR870700331A (ko) 실금 보호대 및 그 제조방법
DK406086A (da) Bbm-1675c og d-antitumor-antibiotica
BR8606551A (pt) Chumacos absorventes e metodo de producao
DE3680775D1 (de) Isoxazolopyridobenzoxazin- und isothiazolopyridobenzoxazinderivate.
KR880700478A (ko) 다공성 전극 및 그 제조방법
DE3687576T2 (de) Bauelement und herstellungsverfahren.
DK9886A (da) Naphthalenderivater og fremstilling deraf
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid